Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hemagglutination Tests | 1 | 2021 | 124 | 0.84 | Why? |
| Ventriculoperitoneal Shunt | 1 | 2019 | 29 | 0.78 | Why? |
| Candidiasis | 2 | 2019 | 334 | 0.68 | Why? |
| Candida | 2 | 2019 | 425 | 0.67 | Why? |
| Prosthesis-Related Infections | 1 | 2019 | 302 | 0.57 | Why? |
| Cerebrospinal Fluid | 2 | 2019 | 234 | 0.32 | Why? |
| Antibodies, Viral | 7 | 2021 | 51949 | 0.26 | Why? |
| Metagenomics | 2 | 2019 | 823 | 0.24 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.23 | Why? |
| Agglutination Tests | 1 | 2021 | 124 | 0.21 | Why? |
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2018 | 72 | 0.19 | Why? |
| Pregnancy Trimester, First | 1 | 2020 | 366 | 0.18 | Why? |
| Immunoglobulin G | 6 | 2021 | 21571 | 0.18 | Why? |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 314 | 0.17 | Why? |
| Nucleic Acid Amplification Techniques | 2 | 2021 | 3388 | 0.16 | Why? |
| Escherichia coli Infections | 1 | 2018 | 348 | 0.14 | Why? |
| Molecular Diagnostic Techniques | 2 | 2021 | 4239 | 0.14 | Why? |
| Hospitals | 4 | 2021 | 11793 | 0.13 | Why? |
| Seroconversion | 2 | 2021 | 2515 | 0.13 | Why? |
| Urinary Tract Infections | 1 | 2018 | 534 | 0.12 | Why? |
| Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 7868 | 0.11 | Why? |
| Orthomyxoviridae | 1 | 2019 | 1168 | 0.11 | Why? |
| Antibody Formation | 2 | 2021 | 4038 | 0.11 | Why? |
| Health Personnel | 6 | 2021 | 29646 | 0.10 | Why? |
| State Medicine | 2 | 2020 | 2847 | 0.10 | Why? |
| Sputum | 1 | 2018 | 1720 | 0.10 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.10 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2019 | 3633 | 0.10 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2019 | 1234 | 0.10 | Why? |
| Polymerase Chain Reaction | 2 | 2021 | 6740 | 0.09 | Why? |
| Sequence Analysis, DNA | 1 | 2018 | 2830 | 0.09 | Why? |
| Dexamethasone | 1 | 2020 | 2055 | 0.09 | Why? |
| Immunoassay | 2 | 2021 | 4485 | 0.09 | Why? |
| Antifungal Agents | 1 | 2019 | 1828 | 0.09 | Why? |
| United Kingdom | 7 | 2021 | 18046 | 0.09 | Why? |
| Bacteremia | 1 | 2018 | 1372 | 0.08 | Why? |
| Point-of-Care Systems | 1 | 2021 | 2955 | 0.08 | Why? |
| Hepatitis C | 1 | 2018 | 1514 | 0.08 | Why? |
| T-Lymphocytes | 2 | 2021 | 6670 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.07 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.07 | Why? |
| Humans | 25 | 2021 | 930598 | 0.07 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 2426 | 0.07 | Why? |
| Electronic Health Records | 1 | 2018 | 3492 | 0.07 | Why? |
| Antibodies, Monoclonal | 2 | 2021 | 8041 | 0.07 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.07 | Why? |
| England | 3 | 2020 | 5116 | 0.07 | Why? |
| Antiviral Agents | 4 | 2021 | 41703 | 0.07 | Why? |
| Population Surveillance | 1 | 2020 | 4967 | 0.06 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.06 | Why? |
| Administration, Oral | 2 | 2020 | 2340 | 0.06 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.06 | Why? |
| Cross Infection | 2 | 2021 | 8675 | 0.06 | Why? |
| Triage | 1 | 2021 | 7151 | 0.06 | Why? |
| Hospitals, Teaching | 2 | 2020 | 1609 | 0.05 | Why? |
| Tertiary Care Centers | 1 | 2019 | 8248 | 0.05 | Why? |
| Health Policy | 1 | 2020 | 6242 | 0.05 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.05 | Why? |
| Injections, Intravenous | 1 | 2020 | 381 | 0.05 | Why? |
| Adult | 9 | 2021 | 244371 | 0.05 | Why? |
| Male | 9 | 2021 | 367725 | 0.05 | Why? |
| Respiration, Artificial | 2 | 2020 | 22116 | 0.04 | Why? |
| Hepatitis C Antibodies | 1 | 2018 | 120 | 0.04 | Why? |
| Carrier Proteins | 1 | 2021 | 513 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2019 | 6817 | 0.04 | Why? |
| Prenatal Diagnosis | 1 | 2020 | 345 | 0.04 | Why? |
| Equipment and Supplies, Hospital | 1 | 2020 | 272 | 0.04 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.04 | Why? |
| Sustained Virologic Response | 1 | 2018 | 378 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Single-Blind Method | 1 | 2020 | 1283 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Transplantation, Homologous | 1 | 2019 | 757 | 0.04 | Why? |
| Aged | 7 | 2021 | 215776 | 0.04 | Why? |
| Drug Resistance, Fungal | 1 | 2017 | 191 | 0.04 | Why? |
| Hospitals, General | 1 | 2021 | 711 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.04 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.04 | Why? |
| Influenza, Human | 1 | 2019 | 10779 | 0.04 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.03 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| Diagnostic Errors | 1 | 2020 | 865 | 0.03 | Why? |
| Incidence | 3 | 2020 | 25622 | 0.03 | Why? |
| Cell Proliferation | 1 | 2021 | 1973 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Ageusia | 1 | 2021 | 918 | 0.03 | Why? |
| RNA Viruses | 1 | 2019 | 824 | 0.03 | Why? |
| Ribavirin | 1 | 2019 | 1182 | 0.03 | Why? |
| Bayes Theorem | 1 | 2021 | 3237 | 0.03 | Why? |
| Asymptomatic Infections | 2 | 2021 | 7218 | 0.03 | Why? |
| Cohort Studies | 3 | 2020 | 36005 | 0.03 | Why? |
| Interferon-gamma | 1 | 2021 | 2711 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2020 | 4260 | 0.03 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.03 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.03 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.03 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.02 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.02 | Why? |
| Epitopes | 1 | 2021 | 4113 | 0.02 | Why? |
| Hepacivirus | 1 | 2018 | 1509 | 0.02 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.02 | Why? |
| Peptides | 1 | 2021 | 2513 | 0.02 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.02 | Why? |
| Anti-Infective Agents | 1 | 2020 | 1766 | 0.02 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| HEK293 Cells | 1 | 2021 | 8394 | 0.02 | Why? |
| Immunoglobulins, Intravenous | 1 | 2019 | 2705 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
| Computational Biology | 1 | 2019 | 4514 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.02 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| RNA, Viral | 2 | 2019 | 32276 | 0.01 | Why? |
| Phylogeny | 1 | 2019 | 13341 | 0.01 | Why? |
| Disease Management | 1 | 2019 | 6841 | 0.01 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.01 | Why? |
| Genome, Viral | 1 | 2019 | 13157 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2019 | 15421 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.01 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.01 | Why? |
| Animals | 1 | 2021 | 78931 | 0.01 | Why? |
| Risk Factors | 1 | 2019 | 71621 | 0.01 | Why? |
| Retrospective Studies | 1 | 2018 | 105322 | 0.00 | Why? |
Jeffery's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(142)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(338)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_